Product Highlight - Etoricoxib (Ebicox)

Life Back in MOTION

Ebicox is a selective COX-2 inhibitor recommended in adults and adolescents 16 years and above for the symptomatic relief of osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis, and the pain and signs of inflammation associated with acute gouty arthritis.^2,3
For the short-term treatment of moderate pain associated with dental surgery.^1,2,3
Usual Recommended Dose: Osteoarthritis: 30-60 mg tablet daily; Rheumatoid arthritis: 60-90 mg tablet daily; Ankylosing spondylitis: 60-90 mg tablet daily; Acute gouty arthritis: 120 mg tablet daily for 8 days; Post-operative dental surgery pain: 90 mg tablet daily for maximum of 3 days.¹

References:
1. Full prescribing information of Etoricoxib (Ebicox) - March 2023.
2. Collantes-Estevez et al: Rapid onset of analgesic effect (at 24 minutes). (Future Rheumatol.(2007) 2 (6) 553. Profound COX-2 Inhibition upto 24 hours (convenient once-daily dosing regimen) (Future Rheumatol.(2007) 2 (6) 548
3. Brooks, P., & Kubler, P. (2006). Etoricoxib for arthritis and pain management. Therapeutics and clinical risk management, 2(1), 45–57.